| Reprogramming of human somatic cells to pluripotency with defined factors IH Park, R Zhao, JA West, A Yabuuchi, H Huo, TA Ince, PH Lerou, ... Nature 451 (7175), 141-146, 2008 | 3726 | 2008 |
| HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers ML Mendillo, S Santagata, M Koeva, GW Bell, R Hu, RM Tamimi, ... Cell 150 (3), 549-562, 2012 | 735 | 2012 |
| Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer DM Dinulescu, TA Ince, BJ Quade, SA Shafer, D Crowley, T Jacks Nature medicine 11 (1), 63-70, 2005 | 714 | 2005 |
| Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells EM Chan, S Ratanasirintrawoot, IH Park, PD Manos, YH Loh, H Huo, ... Nature biotechnology 27 (11), 1033-1037, 2009 | 678 | 2009 |
| The distal fallopian tube: a new model for pelvic serous carcinogenesis CP Crum, R Drapkin, A Miron, TA Ince, M Muto, DW Kindelberger, Y Lee Current Opinion in Obstetrics and Gynecology 19 (1), 3-9, 2007 | 603 | 2007 |
| Systemic endocrine instigation of indolent tumor growth requires osteopontin SS McAllister, AM Gifford, AL Greiner, SP Kelleher, MP Saelzler, TA Ince, ... Cell 133 (6), 994-1005, 2008 | 489 | 2008 |
| Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression S Godar, TA Ince, GW Bell, D Feldser, JL Donaher, J Bergh, A Liu, K Miu, ... Cell 134 (1), 62-73, 2008 | 484 | 2008 |
| Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis RS Watnick, YN Cheng, A Rangarajan, TA Ince, RA Weinberg Cancer cell 3 (3), 219-231, 2003 | 409 | 2003 |
| Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes TA Ince, AL Richardson, GW Bell, M Saitoh, S Godar, AE Karnoub, ... Cancer cell 12 (2), 160-170, 2007 | 393 | 2007 |
| Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y S Jin, KW Scotto Molecular and cellular biology, 1998 | 390 | 1998 |
| Loss of p63 expression is associated with tumor progression in bladder cancer MJ Urist, CJ Di Como, ML Lu, E Charytonowicz, D Verbel, CP Crum, ... The American journal of pathology 161 (4), 1199-1206, 2002 | 347 | 2002 |
| High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer S Santagata, R Hu, NU Lin, ML Mendillo, LC Collins, SE Hankinson, ... Proceedings of the National Academy of Sciences 108 (45), 18378-18383, 2011 | 331 | 2011 |
| Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells H Elmasri, C Karaaslan, Y Teper, E Ghelfi, MQ Weng, TA Ince, ... The FASEB Journal 23 (11), 3865, 2009 | 319 | 2009 |
| Ovarian cancer spheroids use myosin-generated force to clear the mesothelium MP Iwanicki, RA Davidowitz, MR Ng, A Besser, T Muranen, M Merritt, ... Cancer discovery 1 (2), 144-157, 2011 | 317 | 2011 |
| Molecular identification of latent precancers in histologically normal endometrium GL Mutter, TA Ince, JPA Baak, GA Kust, XP Zhou, C Eng Cancer research 61 (11), 4311-4314, 2001 | 307 | 2001 |
| Reference-free deconvolution of DNA methylation data and mediation by cell composition effects EA Houseman, ML Kile, DC Christiani, TA Ince, KT Kelsey, CJ Marsit BMC bioinformatics 17, 1-15, 2016 | 265 | 2016 |
| Taxonomy of breast cancer based on normal cell phenotype predicts outcome S Santagata, A Thakkar, A Ergonul, B Wang, T Woo, R Hu, JC Harrell, ... The Journal of clinical investigation 124 (2), 859-870, 2014 | 231 | 2014 |
| Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element* 210 RA Johnson, TA Ince, KW Scotto Journal of Biological Chemistry 276 (29), 27716-27720, 2001 | 226 | 2001 |
| A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells F Petrocca, G Altschuler, SM Tan, ML Mendillo, H Yan, DJ Jerry, AL Kung, ... Cancer cell 24 (2), 182-196, 2013 | 219 | 2013 |
| Differentiation of NUT midline carcinoma by epigenomic reprogramming BE Schwartz, MD Hofer, ME Lemieux, DE Bauer, MJ Cameron, NH West, ... Cancer research 71 (7), 2686-2696, 2011 | 209 | 2011 |
